Ascendis Pharma A/S (ASND)

237.59 +0.87 (+0.37%) USD  |  NASDAQ  |  Sep 21, 16:00
237.30 -0.29 (-0.12%) After-Hours: 20:00
More

Ascendis Pharma EPS Diluted (TTM) : 13.12 for June 30, 2026

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 13.12
March 31, 2026 8.873
December 31, 2025 -4.197
September 30, 2025 -4.247
June 30, 2025 -4.968
March 31, 2025 -6.292
December 31, 2024 -7.133
September 30, 2024 -8.098
June 30, 2024 -9.340
March 31, 2024 -9.637
December 31, 2023 -9.259
September 30, 2023 -11.39
June 30, 2023 -11.30
March 31, 2023 -10.50
December 31, 2022 -10.86
September 30, 2022 -9.214
June 30, 2022 -7.901
March 31, 2022 -9.359
December 31, 2021 -8.284
September 30, 2021 -9.231
June 30, 2021 -10.20
March 31, 2021 -9.357
December 31, 2020 -9.404
September 30, 2020 -8.176
June 30, 2020 -6.063
Date Value
March 31, 2020 -5.297
December 31, 2019 -5.248
September 30, 2019 -4.261
June 30, 2019 -4.617
March 31, 2019 -3.870
December 31, 2018 -3.780
September 30, 2018 -3.996
June 30, 2018 -4.275
March 31, 2018 -4.655
December 31, 2017 -4.172
September 30, 2017 -3.638
June 30, 2017 -3.220
March 31, 2017 -2.783
December 31, 2016 -2.856
September 30, 2016 -2.829
June 30, 2016 -2.358
March 31, 2016 -2.457
December 31, 2015 -1.553
September 30, 2015 -1.293
June 30, 2015 -1.065
March 31, 2015 -0.4913
December 31, 2014 -0.5598
September 30, 2014 -0.175
June 30, 2014 -0.0293
March 31, 2014 0.0937

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 0.3709
Novo Nordisk A/S 4.092
Evaxion AS -1.054
Genmab A/S 1.263
Zealand Pharma A/S 5.999